97 related articles for article (PubMed ID: 27290814)
1. [FOLLOW-UP OF PATIENTS WITH CLASSICAL HODGIN LYMPHOMA AFTER TREATMENT--NOVEL EVIDENCE AND DILEMMAS. LITERATURE REVIEW].
Milunović V; Jakobac KM; Planinc-Peraica A; Kolonić SO
Lijec Vjesn; 2016; 138(1-2):47-53. PubMed ID: 27290814
[TBL] [Abstract][Full Text] [Related]
2. Hodgkin lymphoma patients in first remission: routine positron emission tomography/computerized tomography imaging is not superior to clinical follow-up for patients with no residual mass.
Dann EJ; Berkahn L; Mashiach T; Frumer M; Agur A; McDiarmid B; Bar-Shalom R; Paltiel O; Goldschmidt N
Br J Haematol; 2014 Mar; 164(5):694-700. PubMed ID: 24313286
[TBL] [Abstract][Full Text] [Related]
3. Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Eichenauer DA; Aleman BMP; André M; Federico M; Hutchings M; Illidge T; Engert A; Ladetto M;
Ann Oncol; 2018 Oct; 29(Suppl 4):iv19-iv29. PubMed ID: 29796651
[No Abstract] [Full Text] [Related]
4. Computed tomography and positron emission tomography/computed tomography surveillance after combined modality treatment of supradiaphragmatic Hodgkin lymphoma: a clinical and economic perspective.
Patel V; Buckstein M; Perini R; Hill-Kayser C; Svoboda J; Plastaras JP
Leuk Lymphoma; 2013 Oct; 54(10):2168-76. PubMed ID: 23331161
[TBL] [Abstract][Full Text] [Related]
5. Surveillance imaging of Hodgkin lymphoma patients in first remission: a clinical and economic analysis.
Lee AI; Zuckerman DS; Van den Abbeele AD; Aquino SL; Crowley D; Toomey C; Lacasce AS; Feng Y; Neuberg DS; Hochberg EP
Cancer; 2010 Aug; 116(16):3835-42. PubMed ID: 20564135
[TBL] [Abstract][Full Text] [Related]
6. The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma.
Goldschmidt N; Or O; Klein M; Savitsky B; Paltiel O
Ann Hematol; 2011 Feb; 90(2):165-71. PubMed ID: 20706721
[TBL] [Abstract][Full Text] [Related]
7. Limited utility of surveillance imaging for detecting disease relapse in patients with non-Hodgkin lymphoma in first complete remission.
Truong Q; Shah N; Knestrick M; Curley B; Hu Y; Craig M; Hamadani M
Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):50-5. PubMed ID: 24119465
[TBL] [Abstract][Full Text] [Related]
8. ACR Appropriateness Criteria: follow-up of Hodgkin's lymphoma.
Ng A; Constine LS; Advani R; Das P; Flowers C; Friedberg J; Hodgson DC; Schwartz CL; Wilder RB; Wilson LD; Yunes MJ
Curr Probl Cancer; 2010; 34(3):211-27. PubMed ID: 20541059
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma.
Sickinger MT; von Tresckow B; Kobe C; Engert A; Borchmann P; Skoetz N
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010533. PubMed ID: 25572491
[TBL] [Abstract][Full Text] [Related]
10. Advanced-stage Hodgkin lymphoma: US/chest radiography for detection of relapse in patients in first complete remission--a randomized trial of routine surveillance imaging procedures.
Picardi M; Pugliese N; Cirillo M; Zeppa P; Cozzolino I; Ciancia G; Pettinato G; Salvatore C; Quintarelli C; Pane F
Radiology; 2014 Jul; 272(1):262-74. PubMed ID: 24708193
[TBL] [Abstract][Full Text] [Related]
11. Loco-regional recurrence after surgical treatment of oral squamous cell carcinoma: Proposals for follow-up imaging based on literature, national guidelines and institutional experience.
Loeffelbein DJ; Eiber M; Mayr P; Souvatzoglou M; Mücke T; von Bomhard A; Kesting MR; Wolff KD
J Craniomaxillofac Surg; 2015 Oct; 43(8):1546-52. PubMed ID: 26189143
[TBL] [Abstract][Full Text] [Related]
12. [After care in Hodgkin lymphoma].
Petrausch U; Samaras P; Mischo A; Stenner F; Tinguely M; Schäfer N; Studer G; Renner C
Praxis (Bern 1994); 2011 Dec; 100(25):1515-20; quiz 1521-2. PubMed ID: 22161876
[No Abstract] [Full Text] [Related]
13. Single or tandem autologous stem-cell transplantation for first-relapsed or refractory Hodgkin lymphoma: 10-year follow-up of the prospective H96 trial by the LYSA/SFGM-TC study group.
Sibon D; Morschhauser F; Resche-Rigon M; Ghez D; Dupuis J; Marçais A; Deau-Fischer B; Bouabdallah R; Sebban C; Salles G; Brice P
Haematologica; 2016 Apr; 101(4):474-81. PubMed ID: 26721893
[TBL] [Abstract][Full Text] [Related]
14. Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma.
El-Galaly TC; Mylam KJ; Bøgsted M; Brown P; Rossing M; Gang AO; Haglund A; Arboe B; Clausen MR; Jensen P; Pedersen M; Bukh A; Jensen BA; Poulsen CB; d'Amore F; Hutchings M
Am J Hematol; 2014 Jun; 89(6):575-80. PubMed ID: 24493389
[TBL] [Abstract][Full Text] [Related]
15. Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma.
Kobe C; Kuhnert G; Kahraman D; Haverkamp H; Eich HT; Franke M; Persigehl T; Klutmann S; Amthauer H; Bockisch A; Kluge R; Wolf HH; Maintz D; Fuchs M; Borchmann P; Diehl V; Drzezga A; Engert A; Dietlein M
J Clin Oncol; 2014 Jun; 32(17):1776-81. PubMed ID: 24799482
[TBL] [Abstract][Full Text] [Related]
16. Positron Emission Tomography Scanning in the Management of Hodgkin Lymphoma Patients: A Single-Institution Experience.
Zabrocka E; Sierko E; Wojtukiewicz MZ
Adv Clin Exp Med; 2016; 25(6):1185-1192. PubMed ID: 28028972
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET in the detection of residual disease and relapse in patients with Hodgkin's lymphoma. Experience from a Swedish centre.
Bjurberg M; Gustavsson A; Ohlsson T; Brun E
Acta Oncol; 2006; 45(6):743-9. PubMed ID: 16938818
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease.
Mauro FR; Chauvie S; Paoloni F; Biggi A; Cimino G; Rago A; Gentile M; Morabito F; Coscia M; Bellò M; Sacchetti GM; Rossi D; Laurenti L; Autore F; Campanelli M; Trastulli F; Nicolai E; Riminucci M; Gaidano G; Guarini A; Gallamini A; Foà R
Leukemia; 2015 Jun; 29(6):1360-5. PubMed ID: 25650091
[TBL] [Abstract][Full Text] [Related]
19. A population-based study of follow-up care for Hodgkin lymphoma survivors: opportunities to improve surveillance for relapse and late effects.
Hodgson DC; Grunfeld E; Gunraj N; Del Giudice L
Cancer; 2010 Jul; 116(14):3417-25. PubMed ID: 20564062
[TBL] [Abstract][Full Text] [Related]
20. Limited clinical benefit for surveillance PET-CT scanning in patients with histologically transformed lymphoma in complete metabolic remission following primary therapy.
Cheah CY; Dickinson M; Hofman MS; George A; Ritchie DS; Prince HM; Westerman D; Harrison SJ; Burbury K; Wolf M; Januszewicz H; Herbert KE; Carney DA; Tam C; Seymour JF
Ann Hematol; 2014 Jul; 93(7):1193-200. PubMed ID: 24595733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
